Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             87 results found
no title author magazine year volume issue page(s) type
1 Activation of the Na+/H+-exchanger is NIH 3T3 fibroblasts expressing the Ha-ras oncogene requires stimulated calcium influx and is associated with rearrangement of the actin cytoskeleton Ritter, M.
 1995
 31 S3 p. S13-
1 p.
 article
2 Active specific immunotherapy with Newcastle Disease Virus modified autologous tumor cells Schirrmacher, V.
 1995
 31 S3 p. S17-
1 p.
 article
3 Adenovirus-mediated gene transfer of the HSV-thymidine kinase gene for the treatment of primary CNS malignancies Eck, S.L.
 1995
 31 S3 p. S20-
1 p.
 article
4 Adjuvant high dose epirubicin and cyclophosphamide with G-CSF support in patients with locally advanced breast cancer Konecny, G.
 1995
 31 S3 p. S36-
1 p.
 article
5 A heat inducible HSP72 associated immunogenic determinant act as a tumor specific recognition structure for NK cells Botzler, C.
 1995
 31 S3 p. S36-
1 p.
 article
6 Amifostine — protection from hematotoxicity and nephrotoxicity induced by chemotherapy Oster, W.
 1995
 31 S3 p. S37-
1 p.
 article
7 An autocrine factor of an ovarian carcinoma cell line induces C-MYC transcripts, DNA-synthesis and apoptosis Krupitza, G.
 1995
 31 S3 p. S24-
1 p.
 article
8 Antibodies from phage libraries clinical imaging trial of a filamentous bacteriophage-derived single chain Fv anti-CEA expressed in E. coli Begent, RHJ
 1995
 31 S3 p. S14-
1 p.
 article
9 Antigens recognized on human tumors by cytolytic T lymphocytes Coulie, Pierre
 1995
 31 S3 p. S19-
1 p.
 article
10 Apoptosis and the treatment of chronic lymphoid malignancies: the B-chronic lymphocytic leukemia (B-CLL) model Caligaris-Cappio, F.
 1995
 31 S3 p. S9-
1 p.
 article
11 A proliferation assay to determine specific T-cell immunity using HLA I-binding peptides Scheibenbogen, C
 1995
 31 S3 p. S23-
1 p.
 article
12 A randomized trial of IFNα and IL-2 ± cisplatinum in advanced melanoma — a preliminary analysis Keilholz, U
 1995
 31 S3 p. S25-
1 p.
 article
13 A stress inducible HSP72 cell surface expression is observed selectively on human tumor cells Wiesner, M.
 1995
 31 S3 p. S36-
1 p.
 article
14 Bacterial endotoxin sensitizes human endothelial cells against radiation-induced programmed cell death through the action of transmembrane TNF-α Einer, G.
 1995
 31 S3 p. S24-
1 p.
 article
15 Bryostatin 1 regulates multi drug resistance by a PKC-independent mechanism Utz, I.
 1995
 31 S3 p. S13-
1 p.
 article
16 CD4 positive, HLA-DR restricted T cell response to human IFN-γ treated sarcoma cells. Functions, specificity and cytokine profiles Heike, M.
 1995
 31 S3 p. S29-
1 p.
 article
17 Cellular immunotherapy of acute leukemia with natural killer cells in an animal model 1995
 31 S3 p. S35-
1 p.
 article
18 Clinical application of haemopoietic growth factors — state of the art Crowther, D.
 1995
 31 S3 p. S6-
1 p.
 article
19 Clinical applications of erythropoietin(EPO) in pediatrics Morschchakova, Elena F.
 1995
 31 S3 p. S33-
1 p.
 article
20 Clinical aspects of cytokine control of B-lymphopoiesis Hiddemann, W.
 1995
 31 S3 p. S9-
1 p.
 article
21 Clinical experience with rH GM-CSF(leucomax) in advanced neoplasias Iosub, A.
 1995
 31 S3 p. S38-
1 p.
 article
22 Clinical results of two different dose regimens with high-dose interferon-alpha and interleukin-2 in advanced renal cell cancer and malignant melanoma Fenchel, K.
 1995
 31 S3 p. S29-
1 p.
 article
23 Clinical trials of anti-angiogenic agents Hawkins, MJ
 1995
 31 S3 p. S14-
1 p.
 article
24 Cytokine gene therapy with gene transfected cells: Long term expression in vivo and therapeutic potential Rosenthal, F.M.
 1995
 31 S3 p. S19-
1 p.
 article
25 Cytokine gene transfer: First clinical trials Gansbacher, B.
 1995
 31 S3 p. S19-
1 p.
 article
26 Detection of tumor cells in the bone marrow of breast cancer patients by cytokeratin 19 — reverse-transcriptase — polymerase chain reaction (RT-PCR) Nestle-Krämling, C.
 1995
 31 S3 p. S35-
1 p.
 article
27 Development and initial clinical studies of TA-HPV in cervical cancer Borysiewicz, L.K.
 1995
 31 S3 p. S17-
1 p.
 article
28 Development of a biological response modifiers system based upon stimulation of blood with ozone ex vivo and reinfusion Bocci, V.
 1995
 31 S3 p. S32-
1 p.
 article
29 Development of a MDR-1 gene specific ribozyme: A molecular approach to the reversal of drug resistance of cancer cells Kiehntopt, M.
 1995
 31 S3 p. S17-
1 p.
 article
30 Differential effects of an ifosfamide treatment on intracellular glutathione (GSH) levels of lymphocyte subsets correlates with immunological functions Multhoff, G.
 1995
 31 S3 p. S37-
1 p.
 article
31 Differentiation and proliferation in haemopoietic cells Whetton, A.D.
 1995
 31 S3 p. S5-
1 p.
 article
32 Effective treatment of radiotherapy-induced thrombocytopenia with interleukin-3 (IL-3) Färber, L.
 1995
 31 S3 p. S30-
1 p.
 article
33 Effect of alpha-2 interferon (a2-INF) FND myelosan(Busulfan) on haematopoiesis and bone marrou environment in patients with chronic myelocytic leukemia(CML) Abdulkadirov, K.
 1995
 31 S3 p. S29-
1 p.
 article
34 Effects of bleomycin on leukotriene production in mast cells in vitro and in patients in vivo Geuenich, S.
 1995
 31 S3 p. S33-
1 p.
 article
35 Effects produced by a new bacterial substance on the processes of cell proliferation Rugal, V.
 1995
 31 S3 p. S37-
1 p.
 article
36 Efficient costimulatory signal for T cell proliferation induced by human lymphoma cells transduced with B7-1 and B7-2 molecules by recombinant adeno-associated virus (AAV) vectors Mangold, Elisabeth
 1995
 31 S3 p. S26-
1 p.
 article
37 Erythropoietin for chronic anemia of cancer: Treatment results and prediction of responsiveness Ludwig, H.
 1995
 31 S3 p. S6-
1 p.
 article
38 Expression and cloning of LST-1: A novel gene in the human TNF region Rollinger-Holzinger, I.
 1995
 31 S3 p. S37-
1 p.
 article
39 Frequency and function of IL-2 receptor α, β and γ cains on blast cells from acute myelocytic leukemia Weidmann, E.
 1995
 31 S3 p. S23-
1 p.
 article
40 Further characterisation of two different resistant human leukemia cell lines with respect to apoptosis induction Stötzer, O.
 1995
 31 S3 p. S34-
1 p.
 article
41 G-CSF and IL-6 serum-levels in patients with myelodysplastic syndromes and aplastic anemia Nerl, C.
 1995
 31 S3 p. S32-
1 p.
 article
42 Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer Philip, Ramila
 1995
 31 S3 p. S35-
1 p.
 article
43 Generation of cytotoxic T lymphocytes (CTL) in HLA haplo- and identical individuals to investigate graft versus leukemia effects Froer, M.
 1995
 31 S3 p. S31-
1 p.
 article
44 Gene transfer-mediated expression of costimulatory melocules to enhance the immunogenicity of human tumor cells Moebius, U.
 1995
 31 S3 p. S25-
1 p.
 article
45 GM-CSF/IL3 fusion protein (pixy 321) and other growth factors in acute myeloid leukemia blasts Tafuri, A.
 1995
 31 S3 p. S5-
1 p.
 article
46 Growth factor receptors as targets for drug development Ullrich, A.
 1995
 31 S3 p. S13-
1 p.
 article
47 Growth factor regulation of normal hematopoiesis Hogge, D.E.
 1995
 31 S3 p. S5-
1 p.
 article
48 Human allogeneic NK-cells activated by IL-2 and IL-12 efficientyl lyse fresh acute leukemia blasts Glass, B.
 1995
 31 S3 p. S23-
1 p.
 article
49 Identification and characterization of murine stem cells with preferential short-term or long-term bone marrow repopulating ability Fibbe, W.E.
 1995
 31 S3 p. S5-
1 p.
 article
50 IL-4 induced upregulation of BCL-2 in CLL patients in vivo and in vitro Karakas, T.
 1995
 31 S3 p. S32-
1 p.
 article
51 Immune reconstitution of severe combined immune deficient (SCID) mice: A potential model for testing immune gene therapy for acute myeloid leukaemia Hollingsworth, S.J.
 1995
 31 S3 p. S26-
1 p.
 article
52 Immunization with anti-idiotype vaccine SCV 106 prolongs survival time of cancer patients with metastatic colorectal cancer: A randomized double blind clinical trial Samonigg, H.
 1995
 31 S3 p. S25-
1 p.
 article
53 Immuno-gene therapy of rat glioma with TGF-β2 antisense and IL-2 gene modified tumor cells Sobol, RE
 1995
 31 S3 p. S20-
1 p.
 article
54 Immunomagnetic removal of tumor cells using monoclonal antibodies against B-cell epitopes or tumor associated breast cancer antigens Brockmeyer, C.
 1995
 31 S3 p. S32-
1 p.
 article
55 Immunotherapeutic approaches directed against minimal residual cancer Pantel, Klaus
 1995
 31 S3 p. S38-
1 p.
 article
56 Immunotherapy in acute leukemias — A new therapeutic approach? Bergmann, L.
 1995
 31 S3 p. S9-
1 p.
 article
57 Induction of apoptosis and anergy in resting human T-lymphocytes after CD3-triggering and its modulation by CD28 and cytokines Müller, Y.
 1995
 31 S3 p. S34-
1 p.
 article
58 Interactions of TGFα and TGFβ in the regulation of epithelial cell growth Leake, Robin
 1995
 31 S3 p. S13-
1 p.
 article
59 Interferon-alpha and vinblastine versus medroxy-progesteronacetat in the treatment of metastatic renal cell carcinoma Kriegmair, M.
 1995
 31 S3 p. S35-
1 p.
 article
60 Interleukin-2 transfected melanoma cells for tumor vaccination. — From animal models to clinical trials — Maass, G.
 1995
 31 S3 p. S18-
1 p.
 article
61 In vivo gene therapy of metastatic melanoma using the HSVtk gene by co-activation of anti-tumour immunity Castleden, Simon
 1995
 31 S3 p. S20-
1 p.
 article
62 Lymphokine induced differentiation of human nonlyphocytic leukemia cell lines Stöckbauer, P.
 1995
 31 S3 p. S31-
1 p.
 article
63 Mechanisms of erythropoietin action Pavlov, Anatol D.
 1995
 31 S3 p. S33-
1 p.
 article
64 Molecular cytokine regulation by interferon-α (IFN-α) in bone marrow stromal cells: A possible paracrine mode of action in chronic myeloid leukemia (CML) Derigs, H.G.
 1995
 31 S3 p. S23-
1 p.
 article
65 Monoclonal antibody (MAB) treatment of resected Dukes C colorectal carcinoma (CRC): A prospective randomized trial Riethmüller, G.
 1995
 31 S3 p. S14-
1 p.
 article
66 Plasmid vaccination for B-cell lymphoma Hawkins, Robert E
 1995
 31 S3 p. S18-
1 p.
 article
67 Post-marketing surveillance study on the treatment of solid tumors with filgrastim Maschek, U.
 1995
 31 S3 p. S30-
1 p.
 article
68 Preclinical and clinical results in breast cancer overexpressing HER-2 Slamon, D.
 1995
 31 S3 p. S14-
1 p.
 article
69 Prostaglandins and leukotrienes modulate proliferation of normal and transformed blood cells Haberl, C.
 1995
 31 S3 p. S33-
1 p.
 article
70 Receptor binding, activation of cAMP dependent protein kinase (PKA) signal transduction pathways and induction of interleukin-8 (IL-8) mRNA by A (1→3)-β-D-glucan biological response modifier in the human monocyte-like cell line U937 Müller, A.
 1995
 31 S3 p. S24-
1 p.
 article
71 Recombinant human stem cell factor protects CD34 positive human myeloid leukemia cells from the chemotherapy-induced apoptosis Hassan, H.T.
 1995
 31 S3 p. S34-
1 p.
 article
72 Recombinant single chain immunotoxins specific for the EGF receptor and ErbB-2 Schmidt, Mathias
 1995
 31 S3 p. S34-
1 p.
 article
73 Retrovirus mediated gene transfer for gene therapy Günzburg, Walter H.
 1995
 31 S3 p. S19-
1 p.
 article
74 Retrovirus-mediated gene transfer of B7.1 into primary acute myeloid leukaemia blasts Buggins, A.S.
 1995
 31 S3 p. S26-
1 p.
 article
75 Sequential interferon alfa 2B with chemotherapy in metastatic ovarian cancer. Phase II. Study Adorjan, G.
 1995
 31 S3 p. S29-
1 p.
 article
76 Strategies for the development of a tumor vaccine for non-Hodgkin's lymphoma Hallek, M.
 1995
 31 S3 p. S18-
1 p.
 article
77 Synergistic cytotoxic and cytostatic interactions between interferon-alpha and chemotherapeutic drugs in human myeloid leukaemia cells Hassan, H.T.
 1995
 31 S3 p. S30-
1 p.
 article
78 Systemic and cellular release of IL-10 in human BMT Holler, E
 1995
 31 S3 p. S24-
1 p.
 article
79 Targeted eradication of ErbB-2 over-expressing tumor cells employing expression of an intracellular antibody directed against the ErbB-2 oncoprotein Deshane, J.
 1995
 31 S3 p. S17-
1 p.
 article
80 The combination of interferon-alpha, all-trans retinoic acid and topical mechlorethamine in the treatment of cutaneous T-cell lymphomas Lin, Xie-Yi
 1995
 31 S3 p. S30-
1 p.
 article
81 The effect of TNF alfa on the cytotoxic activity of natural killer cells in vitro Konjević, G.
 1995
 31 S3 p. S31-
1 p.
 article
82 The use of genetically modified tumor cells as a vaccine in patients with cancer: The definition of intermediate end-points Rankin, E.M.
 1995
 31 S3 p. S18-
1 p.
 article
83 Thrombopoietin (TPO): Basic biology, clinical promise Kaushansky, K.
 1995
 31 S3 p. S6-
1 p.
 article
84 TIL culture and expansion from 42 human tumors. Reinfusion for immunoadoptive therapy in 15 patients: Preliminary data Ridolfi, R.
 1995
 31 S3 p. S31-
1 p.
 article
85 Transfer of the metallothionein gene to CD34+ cells using an original friend virus derived construct confers resistance to cis-platinium derivatives and to alkylating agents Cohen-Haguenauer, Odile
 1995
 31 S3 p. S20-
1 p.
 article
86 Vaccination of rhesus monkeys with an anti-idiotype antibody mumicking Lewis Y: Enhancement of the anti-tumor immune response by repeated administrations of recombinant human GM-CSF. Loibner, H.
 1995
 31 S3 p. S36-
1 p.
 article
87 4-year survival data of patients with advanced renal cell carcinoma treated with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon-alpha2b Pomer, S.
 1995
 31 S3 p. S25-
1 p.
 article
                             87 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands